Dabigatran and rivaroxaban, new oral anticoagulants. New approaches in dentistry

Journal of Clinical and Experimental Dentistry

Volumn 2, Issue 1, 2010, Pages

  Gámez Moreno, Gerardo ^a   Aguilar Salvatierra, Antonio ^a   Martín Piedra, Miguel Ángel ^a   Guardia, Javier ^a   Calvo Guirado, José Luis ^b   Cabrera, Maribel ^a   Lápez Gallardo, Cristina ^a   Castillo, Tania ^a  

^a UNIVERSITY OF GRANADA   (Spain)

^b UNIVERSITY OF MURCIA   (Spain)

Author keywords

Anticoagulants; Dabigatran; Dentistry; Heparin; Rivaroxaban; Warfarin

Indexed keywords

EID: 84865062606     PISSN: None     EISSN: 19895488     Source Type: Journal    
DOI: 10.4317/jced.2.e1     Document Type: Article

References (18)

1. Schenk JF, Stephan B, Kusma M, Groß J, Eichler H. Orthopedic patients with or without thrombophilia : Diagnostic, therapy and perioperative strategies. Orthopade. 2009 Sep 4.
2. Gámez-Moreno G, Guardia J, Cutando A, Calvo-Guirado JL. Pharmacological interactions of vasoconstrictors. Med Oral Patol Oral Cir Bucal. 2009;14:E20-7.
3. Gámez-Moreno G, Guardia J, Cutando A, Calvo-Guirado JL. Pharmacological interactions of anti-inflammatory-analgesics in odontology. Med Oral Patol Oral Cir Bucal. 2009 ;14:E81-9.
4. Warwick D, Friedman RJ, Agnelli G, Gil-Garay E, Johnson K, FitzGerald G, et al. Insufficient duration of venous thromboembolism prophylaxis after total hip or knee replacement when compared with the time course of thromboembolic events: findings from the Global Orthopaedic Registry. J Bone Joint Surg Br. 2007;89:799-807.
5. Ezekowitz MD, Reilly PA, Nehmiz G, Simmers TA, Nagarakanti R, Parcham-Azad K, et al. Dabigatran with or without concomitant aspirin compared with warfarin alone in patients with nonvalvular atrial fibrillation (PETRO Study). Am J Cardiol. 2007;100:1419-26.
6. Eriksson BI, Dahl OE, Rosencher N, Kurth AA, Van Dijk CN, Frostick SP, et al. Oral dabigatran etexilate vs. subcutaneous enoxaparin for the prevention of venous thromboembolism after total knee replacement: the RE-MODEL randomized trial. J Thromb Haemost. 2007;5:2178-85.
7. Eriksson BI, Dahl OE, Rosencher N, Kurth AA, Van Dijk CN, Frostick SP, et al. Dabigatran etexilate versus enoxaparin for prevention of venous thromboembolism after total hip replacement: a randomised, double-blind, non-inferiority trial. Lancet. 2007;370:949-56.
8. Ginsberg JS, Davidson BL, Comp PC, Francis CW, Friedman RJ, Huo MH, et al. Oral thrombin inhibitor dabigatran etexilate vs North American enoxaparin regimen for prevention of venous thromboembolism after knee arthroplasty surgery. J Arthroplasty. 2009;24:1-9.
9. Bounameaux H. The novel anticoagulants: entering a new era.Swiss Med Wkly. 2009;139:60-4.
10. Turpie AG. New oral anticoagulants in atrial fibrillation. Eur Heartn J. 2008;29:155-65.
11. Camm AJ. The RE-LY study: Randomized Evaluation of Longterm anticoagulant therapY: dabigatran vs. warfarin. Eur Heart J. 2009;30:2554-5.
12. Connolly SJ, Ezekowitz MD, Yusuf S, Eikelboom J, Oldgren J, Parekh A, et al. Dabigatran versus warfarin in patients with atrial fi- brillation. N Engl J Med. 2009;361:1139-51.
13. Eriksson BI, Borris LC, Friedman RJ, Haas S, Huisman MV, Kakkar AK, et al. Rivaroxaban versus enoxaparin for thromboprophylaxis after hip arthroplasty. N Engl J Med. 2008;358:2765-75.
14. Kakkar AK, Brenner B, Dahl OE, Eriksson BI, Mouret P, Muntz J, et al. Extended duration rivaroxaban versus short-term enoxaparin for the prevention of venous thromboembolism after total hip arthroplasty: a double-blind, randomised controlled trial. Lancet. 2008;372:31-9.
15. Lassen MR, Ageno W, Borris LC, Lieberman JR, Rosencher N, Bandel TJ, et al. Rivaroxaban versus enoxaparin for thromboprophylaxis after total knee arthroplasty. N Engl J Med. 2008;358:2776-86.
16. Jiménez Y, Poveda R, Gavaldá C, Margaix M, Sarrián G. An update on the management of anticoagulated patients programmed for dental extractions and surgery. Med Oral Patol Oral Cir Bucal.
17. OrdovÁs Baines JP, Climent Grana E, Jover Botella A, Valero García I. Dabigatran and rivaroxaban, new oral anticoagulants for the treatment of venous thromboembolism. Farm Hosp. 2009;33:125-33.
18. Heindl B, Spannagl M. New oral anticoagulants : Consequences for perioperative coagulation diagnostics and therapy. Anaesthesist. 2009.